Diego H. Castrillón

18.7k total citations · 6 hit papers
111 papers, 12.4k citations indexed

About

Diego H. Castrillón is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Diego H. Castrillón has authored 111 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 27 papers in Oncology and 27 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Diego H. Castrillón's work include FOXO transcription factor regulation (28 papers), Reproductive Biology and Fertility (18 papers) and Endometrial and Cervical Cancer Treatments (12 papers). Diego H. Castrillón is often cited by papers focused on FOXO transcription factor regulation (28 papers), Reproductive Biology and Fertility (18 papers) and Endometrial and Cervical Cancer Treatments (12 papers). Diego H. Castrillón collaborates with scholars based in United States, China and United Kingdom. Diego H. Castrillón's co-authors include Ronald A. DePinho, Ramya Kollipara, James W. Horner, Steven A. Wasserman, Teresa D. Gallardo, George B. John, Lili Miao, Norman E. Sharpless, Nabeel Bardeesy and D. Gary Gilliland and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Diego H. Castrillón

110 papers receiving 12.3k citations

Hit Papers

FoxOs Are Critical Mediators of Hematopoietic Stem Cell... 1996 2026 2006 2016 2007 2007 2003 2001 2005 400 800 1.2k

Peers

Diego H. Castrillón
Ian Chambers United Kingdom
Jan Kitajewski United States
Katia Manova United States
James W. Horner United States
Carol B. Ware United States
Diego H. Castrillón
Citations per year, relative to Diego H. Castrillón Diego H. Castrillón (= 1×) peers Mitsuo Oshimura

Countries citing papers authored by Diego H. Castrillón

Since Specialization
Citations

This map shows the geographic impact of Diego H. Castrillón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego H. Castrillón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego H. Castrillón more than expected).

Fields of papers citing papers by Diego H. Castrillón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego H. Castrillón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego H. Castrillón. The network helps show where Diego H. Castrillón may publish in the future.

Co-authorship network of co-authors of Diego H. Castrillón

This figure shows the co-authorship network connecting the top 25 collaborators of Diego H. Castrillón. A scholar is included among the top collaborators of Diego H. Castrillón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego H. Castrillón. Diego H. Castrillón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hao, Kyle Molberg, Kelley Carrick, et al.. (2024). Expression and Prognostic Significance of LAG-3, TIGIT, VISTA, and IDO1 in Endometrial Serous Carcinoma. Modern Pathology. 37(8). 100532–100532. 4 indexed citations
3.
Murphy, Kathleen M., Kelley Carrick, Katja Gwin, et al.. (2021). Rare Complete Hydatidiform Mole With p57 Expression in Villous Mesenchyme: Case Report and Review of Discordant p57 Expression in Hydatidiform Moles. International Journal of Gynecological Pathology. 41(1). 45–50. 6 indexed citations
4.
Li, Hao‐Dong, Changzheng Lu, He Zhang, et al.. (2020). A PoleP286R mouse model of endometrial cancer recapitulates high mutational burden and immunotherapy response. JCI Insight. 5(14). 22 indexed citations
5.
Wang, Zixi, Kenian Chen, Yuemeng Jia, et al.. (2020). Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes. Nature Cancer. 1(9). 909–922. 38 indexed citations
6.
Cuevas, Ileana, Subhransu S. Sahoo, Vinod Kumar, et al.. (2019). Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition. Proceedings of the National Academy of Sciences. 116(51). 25880–25890. 45 indexed citations
7.
Strickland, Amanda, et al.. (2018). PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia. International Journal of Gynecological Pathology. 38(6). 503–513. 20 indexed citations
8.
Aguilera, Kristina Y., Huocong Huang, Wenting Du, et al.. (2017). Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 16(11). 2473–2485. 88 indexed citations
9.
Wang, Miao, Mary Topalovski, Jason E. Toombs, et al.. (2015). Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer. Cancer Research. 75(23). 5058–5069. 36 indexed citations
10.
Aguilera, Kristina Y., Lee B. Rivera, Hoon Hur, et al.. (2013). Collagen Signaling Enhances Tumor Progression after Anti-VEGF Therapy in a Murine Model of Pancreatic Ductal Adenocarcinoma. Cancer Research. 74(4). 1032–1044. 76 indexed citations
11.
Nakada, Yuji, Thomas G. Stewart, Christopher G. Peña, et al.. (2013). The LKB1 Tumor Suppressor as a Biomarker in Mouse and Human Tissues. PLoS ONE. 8(9). e73449–e73449. 15 indexed citations
12.
Baker, Michael D., et al.. (2013). Gonadal Expression of Foxo1, but Not Foxo3, Is Conserved in Diverse Mammalian Species1. Biology of Reproduction. 88(4). 103–103. 48 indexed citations
13.
Akbay, Esra A., Christopher G. Peña, Yuji Nakada, et al.. (2012). Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis. Oncogene. 32(17). 2211–2219. 24 indexed citations
14.
Zhou, Wen, Qian Cao, Yan Peng, et al.. (2009). FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and Inflammation. Gastroenterology. 137(4). 1403–1414. 113 indexed citations
15.
Dejean, Anne S., Daniel R. Beisner, Irene L. Ch’en, et al.. (2009). Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nature Immunology. 10(5). 504–513. 172 indexed citations
16.
Akbay, Esra A., Cristina M. Contreras, Samanthi A. Perera, et al.. (2008). Differential Roles of Telomere Attrition in Type I and II Endometrial Carcinogenesis. American Journal Of Pathology. 173(2). 536–544. 25 indexed citations
17.
Lees‐Murdock, Diane J., et al.. (2008). DNA methyltransferase loading, but not de novo methylation, is an oocyte-autonomous process stimulated by SCF signalling. Developmental Biology. 321(1). 238–250. 24 indexed citations
18.
John, George B., et al.. (2008). Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth. Developmental Biology. 321(1). 197–204. 317 indexed citations
19.
Paik, Ji-Hye, Ramya Kollipara, Gerald Chu, et al.. (2007). FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis. Cell. 128(2). 309–323. 859 indexed citations breakdown →
20.
Rao, Gautam G., et al.. (2005). Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles. American Journal of Obstetrics and Gynecology. 192(5). 1362–1364. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026